Human kallikrein of mammalian cell expression as well as coding gene and application thereof
A technology of kallikrein and coding genes, which is applied in the field of trace detection of recombinant proteins, can solve the problems of protein molecular weight and charge difference, low protein biological activity, high-efficiency expression, etc., and achieve the effect of high accuracy and sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0082] Example 1 Optimization design of recombinant hK1 gene
[0083] 1. Codon optimization
[0084] Integrating the cDNA sequence information of the human kallikrein-1 sequence (Homo sapiens kallikrein1) published in GenBank and the amino acid sequence of the marketed product human kallikrein-1, determine the cDNA sequence (GenBank accession number: BC005313) (Gene without codon optimization, original gene) and the published amino acid sequence of human kallikrein 1 (Homo sapiens kallikrein) (GenBank accession number: AAA59455.1) after codon optimization of this gene, the present invention is obtained The recombinant hK1 gene, as shown in SEQ ID No:1.
[0085] The following is the codon optimization of recombinant hK1, and the comparison of the parameters before and after optimization is as follows:
[0086] 1. Codon Adaptation Index (CAI)
[0087] by Figure 2-a It can be seen that before the codon optimization, by calculation, the codon adaptation index (CAI) of the recombinant hK...
Example Embodiment
[0098] Example 2: Construction of recombinant hK1 gene expression vector in mammalian cells
[0099] 1. Recombinant hK1 gene expression vector construction in adherent mammalian cell CHO-K1
[0100] The optimized recombinant hK1 (such as SEQ ID NO: 1) was directly fused with the optimized fragment of the signal peptide gene (shown in SEQ ID No: 3) of the optimized Rattus norvegicus Anionic trypsin-1 protein, and constructed into the pUC57 plasmid (Provided by Nanjing GenScript Technology Co., Ltd.), a long-term preservation plasmid was obtained, which was recorded as pUC57-opt-hK1 plasmid. Using the pUC57-opt-hK1 plasmid as the template, the upstream primer P1 introduces HindIII and the downstream primer P2 introduces the BamHI restriction site for PCR amplification. The primer sequences used are as follows:
[0101] Upstream primer P1: CCCAAGCTTGCCACCATGTCCG
[0102] Downstream primer P2: CGCGGATCCTCAACTGTTTTCAGCAAT
[0103] The total reaction volume is 50μL, of which 2.5μL of the p...
Example Embodiment
[0109] Example 3: Preparation of CHO host cells containing optimized recombinant hK1 gene
[0110] 1. Preparation of CHO-K1 adherent host cell containing optimized recombinant hK1 gene
[0111] Spread an appropriate amount of CHO-K1 (CCL-61, purchased from ATCC) cells in a 24-well plate, and then add different concentrations of G418 (E859-5G, purchased from Amresco) with 5% FBS (FSP500, purchased from Jitai (Bio) DMEM / F12 (MD207-050, purchased from Merck) medium. After 2 weeks, MTT (0793-5G, purchased from Amresco) method determined the working concentration of G418 to be between 400-800ug / mL, and the working concentration of G418 in this application is 600μg / mL, see Figure 7-a .
[0112] After electrotransfecting the correctly sequenced pCMV13-opt-hK1 plasmid into CHO-K1 cells, add G418 medium with a concentration of 600 μg / mL and place it at 37°C, 5% CO 2 In the incubator. Two weeks later, multiple cell clusters were observed under the microscope. Through the limiting dilution...
PUM
Property | Measurement | Unit |
---|---|---|
Relative molecular mass | aaaaa | aaaaa |
Relative molecular mass | aaaaa | aaaaa |
Relative molecular mass | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap